(Q30558464)

12 October 2017

1 reference

29 April 2021

1 reference

PubMed publication ID

22907121

title

Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence (English)

1 reference

12 October 2017

1 reference

30 May 2020

1 reference

29 April 2021

1 reference

29 April 2021

3

Paolo Fusar-Poli

0 references

Andrea Schmitt

object named as

Andrea Schmitt

4

0 references

Peter Falkai

object named as

Peter Falkai

5

0 references

Alkomiet Hasan

2

object named as

Alkomiet Hasan

1 reference

12 October 2017

Berend Malchow

1

1 reference

12 October 2017

Thomas Wobrock

6

1 reference

12 October 2017

21 August 2012

1 reference

European Archives of Psychiatry and Clinical Neuroscience

12 October 2017

1 February 2013

4 references

19 March 2019

12 September 2019

30 May 2020

29 April 2021

5 references

12 October 2017

19 March 2019

12 September 2019

30 May 2020

29 April 2021

263

1 reference

12 October 2017

1

1 reference

12 October 2017

3-13

1 reference

Creative Commons Attribution 4.0 International

12 October 2017

1 reference

https://scigraph.springernature.com/pub.10.1007/s00406-012-0346-3

29 April 2021

0 references

0 references

cites work

Parietal lobe volume deficits in adolescents with schizophrenia and adolescents with cannabis use disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

A systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Schizophrenia as a disorder of disconnectivity

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

The impact of substance use on brain structure in people at high risk of developing schizophrenia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuse

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Comorbid substance abuse and brain morphology in recent-onset psychosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Brain neuroimaging in cannabis use: a review

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Lack of hippocampal volume change in long-term heavy cannabis users

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Compounded brain volume deficits in schizophrenia-alcoholism comorbidity

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Studies of individuals with schizophrenia never treated with antipsychotic medications: a review

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Precipitation and determination of the onset and course of schizophrenia by substance abuse--a retrospective and prospective study of 232 population-based first illness episodes

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Psychopathology in dual diagnosis and non-addicted schizophrenics--are there differences?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

A review of MRI findings in schizophrenia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Thalamic volumes in patients with first-episode schizophrenia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Effects of frequent marijuana use on brain tissue volume and composition

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Meta-analysis of regional brain volumes in schizophrenia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Dual diagnosis: a review of etiological theories

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Prevalence of alcohol and drug abuse in schizophrenic inpatients

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Suicide and schizophrenia: data from a prospective community treatment study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Drug abuse in schizophrenic patients: clinical correlates and reasons for use.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Influence of cannabis abuse on schizophrenic psychopathology

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Cannabis use and brain structural alterations in first episode schizophrenia--a region of interest, voxel based morphometric study.

20 June 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0346-3

Cannabis and brain morphology in recent-onset schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0346-3

Cannabis and schizophrenia: results of a follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0346-3

Cannabis use and callosal white matter structure and integrity in recent-onset schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0346-3

Magnetic resonance imaging of the thalamus in first-episode psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0346-3

A transcranial magnetic stimulation study of the effects of cannabis use on motor cortical inhibition and excitability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0346-3

Mapping grey matter reductions in schizophrenia: an anatomical likelihood estimation analysis of voxel-based morphometry studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0346-3

A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0346-3

Reduced cortical thickness as an outcome of differential sensitivity to environmental risks in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0346-3

A volumetric MRI study of the entorhinal cortex in first episode neuroleptic-naive schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0346-3

Substance use disorder and the early course of illness in schizophrenia and affective psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0346-3

Altered brain tissue composition in heavy marijuana users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0346-3

Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0346-3

Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0346-3

Schizophrenia, alcohol abuse, and violent behavior: a 26-year followup study of an unselected birth cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0346-3

Decreased frontal white-matter volume in chronic substance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0346-3

Smaller anterior hippocampal formation volume in antipsychotic-naive patients with first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0346-3

Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0346-3

Impact of cannabis use on thalamic volume in people at familial high risk of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0346-3

Schizophrenia: the fundamental questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0346-3

Greater white and grey matter changes associated with early cannabis use in adolescent-onset schizophrenia (AOS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0346-3

Cerebellar white-matter changes in cannabis users with and without schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0346-3

Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Recent-onset schizophrenia and adolescent cannabis use: MRI evidence for structural hyperconnectivity?

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Effects of cocaine on hospital course in schizophrenia.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3560946

Antipsychotic medications and brain volume: do we have cause for concern?

26 November 2018

1 reference

12 December 2020

Cannabis abuse and the course of recent-onset schizophrenic disorders

1 reference

12 December 2020

Temporolimbic volume reductions in schizophrenia

1 reference

12 December 2020

Substance use: a powerful predictor of relapse in schizophrenia

1 reference

12 December 2020

Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes

1 reference

12 December 2020

Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia

1 reference

12 December 2020

Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders

1 reference

12 December 2020

10.1007/S00406-012-0346-3

Identifiers

DOI

1 reference

Dimensions Publication ID

12 October 2017

0 references

1 reference

12 October 2017

PubMed publication ID

22907121

1 reference